These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 36796001

  • 1. Pharmacokinetic and Pharmacodynamic Comparison of Fluticasone Propionate/Formoterol Fumarate Administered via a Pressurized Metered-Dose Inhaler and a Novel Breath-Actuated Inhaler in Healthy Volunteers.
    Dissanayake S, Mundin G, Woodward J, Lomax M, Dalvi P.
    J Aerosol Med Pulm Drug Deliv; 2023 Apr; 36(2):65-75. PubMed ID: 36796001
    [Abstract] [Full Text] [Related]

  • 2. An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma.
    Usmani O, Roche N, Marshall J, Danagher H, Price D.
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
    Murphy KR, Dhand R, Trudo F, Uryniak T, Aggarwal A, Eckerwall G.
    Respir Med; 2015 Feb; 109(2):170-9. PubMed ID: 25596138
    [Abstract] [Full Text] [Related]

  • 4. A Randomized, Crossover Trial Evaluating Patient Handling, Preference, and Ease of Use of the Fluticasone Propionate/Formoterol Breath-Triggered Inhaler.
    Bell D, Mansfield L, Lomax M.
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):425-434. PubMed ID: 28683212
    [Abstract] [Full Text] [Related]

  • 5. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort® (budesonide/formoterol) pressurized metered dose inhaler.
    Gillen M, Forte P, Svensson JO, Lamarca R, Burke J, Rask K, Larsdotter Nilsson U, Eckerwall G.
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [Abstract] [Full Text] [Related]

  • 6. Ethnic Sensitivity Study of the Extrafine, Single-Inhaler, Triple Therapy Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide Pressurized Metered Dose Inhaler in Japanese and Caucasian Healthy Individuals: A Randomized, Double-Blind, Single-Dose Crossover Study.
    Cella M, Täubel J, Delestre-Levai I, Tulard A, Vele A, Georges G.
    Clin Ther; 2021 Nov; 43(11):1934-1947.e4. PubMed ID: 34600734
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial.
    Płoszczuk A, Bosheva M, Spooner K, McIver T, Dissanayake S.
    Ther Adv Respir Dis; 2018 Nov; 12():1753466618777924. PubMed ID: 29857783
    [Abstract] [Full Text] [Related]

  • 8. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
    Rony F, Cortellini M, Guasconi A, Mathews KS, Piccinno A, Poli G, Vanhoutte F, Klein J.
    Pulm Pharmacol Ther; 2024 Jun; 85():102299. PubMed ID: 38663512
    [Abstract] [Full Text] [Related]

  • 9. Bronchodilating effects of a new beclometasone dipropionate plus formoterol fumarate formulation via pressurized metered-dose inhaler in asthmatic children: a double-blind, randomized, cross-over clinical study.
    Pohunek P, Varoli G, Reznichenko Y, Mokia-Serbina S, Brzostek J, Kostromina V, Kaladze M, Muraro A, Carzana E, Armani S, Kaczmarek J.
    Eur J Pediatr; 2021 May; 180(5):1467-1475. PubMed ID: 33404895
    [Abstract] [Full Text] [Related]

  • 10. Salmeterol/fluticasone through breath-actuated inhaler versus pMDI: a randomized, double-blind, 12 weeks study.
    Dhar R, Salvi S, Rajan S, Dalal S, Tikkiwal S, Bhagat R, Ahmed MM, Balki A, Jain M, Gogtay J.
    J Asthma; 2015 May; 52(10):1065-72. PubMed ID: 26288199
    [Abstract] [Full Text] [Related]

  • 11. Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis.
    Levy ML, Hardwell A, McKnight E, Holmes J.
    Prim Care Respir J; 2013 Dec; 22(4):406-11. PubMed ID: 24042172
    [Abstract] [Full Text] [Related]

  • 12. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
    Wolthers OD, Moore A, Mersmann S, Dissanayake S.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma.
    Kuna P, Govoni M, Lucci G, Scuri M, Acerbi D, Stelmach I.
    Br J Clin Pharmacol; 2015 Sep; 80(3):569-80. PubMed ID: 25808292
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of Beclomethasone Dipropionate Delivered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Subjects.
    Small CJ, Gillespie M.
    J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):182-190. PubMed ID: 28937845
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
    Kappeler D, Sommerer K, Kietzig C, Huber B, Woodward J, Lomax M, Dalvi P.
    Respir Med; 2018 May; 138():107-114. PubMed ID: 29724381
    [Abstract] [Full Text] [Related]

  • 16. The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
    Darken P, DePetrillo P, Reisner C, St Rose E, Dorinsky P.
    Pulm Pharmacol Ther; 2018 Jun; 50():11-18. PubMed ID: 29544728
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.
    Dunn LJ, Kerwin EM, DeAngelis K, Darken P, Gillen M, Dorinsky P.
    Pulm Pharmacol Ther; 2020 Feb; 60():101873. PubMed ID: 31841699
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 Feb; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 19. Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults.
    Dorinsky P, DePetrillo P, DeAngelis K, Trivedi R, Darken P, Gillen M.
    Clin Ther; 2020 Apr; 42(4):634-648. PubMed ID: 32253054
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T, Hubbell J, Xuan F, Cutler DL, Meehan AG, Kantesaria B, Wittmer BA.
    Int J Chron Obstruct Pulmon Dis; 2013 Apr; 8():107-16. PubMed ID: 23525511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.